These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34045800)

  • 1. Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors.
    Reddy PR; Samavedam S; Aluru N; Boggu R
    Indian J Crit Care Med; 2021 Apr; 25(4):366-368. PubMed ID: 34045800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the prognosis of non-hypertensive, COVID-19 patients treated with renin-angiotensin-aldosterone system inhibitors more uncertain?
    García Martínez JJ; Wozniak H; Salamin P; Giraud R; Le Terrier C; Bendjelid K
    Physiol Rep; 2022 Nov; 10(22):e15512. PubMed ID: 36397298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of "Cycle Threshold" in Confirmed COVID-19 Patients.
    Rajyalakshmi B; Samavedam S; Reddy PR; Aluru N
    Indian J Crit Care Med; 2021 Mar; 25(3):322-326. PubMed ID: 33790515
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis.
    Kaur U; Chakrabarti SS; Patel TK
    Ther Adv Drug Saf; 2021; 12():20420986211011345. PubMed ID: 34035891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
    Chen R; Yang J; Gao X; Ding X; Yang Y; Shen Y; He C; Xiang H; Ke J; Yuan F; Cheng R; Lv H; Li P; Zhang L; Liu C; Tan H; Huang L
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1974-1983. PubMed ID: 33006442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
    Coto E; Avanzas P; Gómez J
    Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.
    Loader J; Lampa E; Gustafsson S; Cars T; Sundström J
    J Am Heart Assoc; 2021 Aug; 10(15):e021154. PubMed ID: 34320843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin-aldosterone system blockers on adverse outcomes in COVID-19 patients.
    Vinod P; Krishnappa V; Rathell W; Dogbey G; Patel H; Herzog W
    Cardiology; 2024 Jul; ():. PubMed ID: 39038438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
    Pan W; Zhang J; Wang M; Ye J; Xu Y; Shen B; He H; Wang Z; Ye D; Zhao M; Luo Z; Liu M; Zhang P; Gu J; Liu M; Li D; Liu J; Wan J
    Hypertension; 2020 Sep; 76(3):732-741. PubMed ID: 32654555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study.
    Sato K; White N; Fanning JP; Obonyo N; Yamashita MH; Appadurai V; Ciullo A; May M; Worku ET; Helms L; Ohshimo S; Juzar DA; Suen JY; Bassi GL; Fraser JF; Arora RC;
    BMC Cardiovasc Disord; 2022 Mar; 22(1):123. PubMed ID: 35321649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher M; Najafi MH; Behzad S
    Iran J Microbiol; 2021 Dec; 13(6):728-736. PubMed ID: 35222849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between Chronic Use of Renin-Angiotensin-Aldosterone System Blockers and in-Hospital Adverse Events among COVID-19 Patients with Hypertension.
    Cetinkal G; Kocas BB; Ser OS; Kilci H; Yildiz SS; Ozcan SN; Verdi Y; Altinay M; Kilickesmez K
    Sisli Etfal Hastan Tip Bul; 2020; 54(4):399-404. PubMed ID: 33364877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    de Abajo FJ; Rodríguez-Martín S; Lerma V; Mejía-Abril G; Aguilar M; García-Luque A; Laredo L; Laosa O; Centeno-Soto GA; Ángeles Gálvez M; Puerro M; González-Rojano E; Pedraza L; de Pablo I; Abad-Santos F; Rodríguez-Mañas L; Gil M; Tobías A; Rodríguez-Miguel A; Rodríguez-Puyol D;
    Lancet; 2020 May; 395(10238):1705-1714. PubMed ID: 32416785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.
    Gressens SB; Leftheriotis G; Dussaule JC; Flamant M; Levy BI; Vidal-Petiot E
    Front Physiol; 2021; 12():624052. PubMed ID: 33692701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of renin-angiotensin-aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies.
    Zhang K; Cao L; Xuan N; Huang T; Tian B; Cui W; Zhang G; Zhang S
    J Intensive Med; 2022 Oct; 2(4):282-290. PubMed ID: 36785646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
    Baral R; White M; Vassiliou VS
    Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.